PDGFRA and gastrointestinal stromal tumor: For instance, the genetic hallmarks of GIST patients have been revealed to show constitutively activating mutations of proto-oncogene KIT (~85% of cases) and PDGFRA (~7% of cases) which encodes platelet-derived growth factor receptor alpha (PDGFRα) [4].